-
Echosens Wins in Germany a Major Trial for IP Infringement Against Wuxi Hisky Medical
en-cphi.cn
May 11, 2017
For more than fifteen years, Echosens has developed and sold worldwide its FibroScan® devices that utilise its unique VCTE™ technology, which is protected worldwide by a portfolio of several patents.
-
Allergan, Novartis sign NASH clinical trials pact
pharmatimes
April 19, 2017
Allergan is expanding its research and development programme on non-alcoholic steatohepatitis (NASH) through a ...
-
Circassia abandons allergy programme after trial failure
pharmatimes
April 19, 2017
British biotech Circassia has announced the death of its allergy programme following a second key trial failure, choosing to focus all of its efforts on its respiratory business instead.
-
Roche’s Alecensa beats Pfizer’s Xalkori in lung cancer trial
pharmatimes
April 11, 2017
Roche has presented late-stage data showing that its Alecensa was superior to Pfizer’s Xalkori on progression-free ...
-
Allergan reports success in late-stage acne trials
pharmatimes
March 29, 2017
Dublin, Ireland-based drugmaker Allergan and US partner Paratek Pharmaceuticals have reported that two Phase III trials assessing sarecycline for the treatment of moderate to severe ...
-
Lynparza Phase III data demonstrates progression-free survival in ovarian cancer
europeanpharmaceuticalreview
March 20, 2017
AstraZeneca’s Phase III SOLO-2 trial demonstrated a significant improvement in progression-free survival (PFS) in germline BRCA-mutated (gBRCA), platinum-sensitive...
-
Trial to test fracture prevention combo in brittle bone patients
pharmatimes
January 17, 2017
The National Institute for Health Research Efficacy and Mechanism Evaluation (EME) Programme is funding a new £1.5 million trial testing a combination of therapies to prevent rapture in patients with brittle bone disease.
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight June 2024: Globalization on the Go
